| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal: TA929: Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction |
|
Medicine details |
|
| Medicine name | empagliflozin (Jardiance®) |
| Formulation | tablet |
| Reference number | 4811 |
| Indication | Treatment for symptomatic chronic heart failure with preserved or mildly reduced ejection fraction in adults |
| Company | Boehringer Ingelheim Ltd |
| BNF chapter | Cardiovascular system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 05/10/2023 |
| NICE guidance | |